Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Processa Pharmaceuticals Inc
About PCSA
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of Next Generation Cancer therapy (NGC) small molecules. The three NGC treatments in its pipeline are NGC-Capecitabine (NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem) and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri) and two non-oncology drug assets are PCS12852, and PCS499. NGC-Cap is a combination of PCS6422 and capecitabine, capecitabine being the oral prodrug of the cancer drug 5-fluorouracil.PCS3117 is an oral analog of gemcitabine that is converted to its active metabolite by a different enzyme system than gemcitabine. PCS11T is a prodrug of the active metabolite of irinotecan (SN-38). PCS12852 is a specific and potent 5HT4 agonist that is in Phase IIB and is a potential treatment for diabetic gastroparesis patients. PCS499 is a drug that can be used to treat unmet medical needs and conditions caused by multiple pathophysiological changes.
Market Capitalisation
$5.60M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
45.8K
High today
$2.50
Low today
$2.30
Open price
$2.30
52-week high
$19.63
52-week low
$1.76
Ready to start your investing journey with Stake?
Open an accountHow do I buy PCSA shares in Australia?
Buying PCSA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Processa Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in PCSA
What is the ticker symbol of Processa Pharmaceuticals Inc?
The ticker symbol for Processa Pharmaceuticals Inc is PCSA.
How much is one share of PCSA?
One share of PCSA is valued at $2.05 as of 10 June 2026.
What is the market capitalisation of Processa Pharmaceuticals Inc PCSA?
As of 10 June 2026 Processa Pharmaceuticals Inc has a market cap of $5.60M.
What is the 52-week high for Processa Pharmaceuticals Inc stock?
The Processa Pharmaceuticals Inc 52-week high stock price is $19.63.
What is the 52-week low for Processa Pharmaceuticals Inc stock?
The Processa Pharmaceuticals Inc 52-week low stock price is $1.76.
Can I buy PCSA shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy PCSA shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in PCSA on Stake
- Buy PCSA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of PCSA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
PCSA related stocks